Notification
Get Free Job Alerts in your Email - Subscribe now
Advanced Centre for Treatment, Research & Education in Cancer Notification 2018: Jr. Assistant & Attendant
Applications are invited for filling up the following vacancies :
Organisation | Posts | Qualification | Salary |
Jr. Assistant | 01 Post | Graduate degree with Computer course in office software | Rs.17,000/- per month |
Attendant | 01 Post | 12th Std. Passed | Rs.10,000/- per month |
Duration : Six months and extendable.
Eligible Candidates may attend the walk in interview along with Bio-data,Original Certificate, Photo,Pan Card etc. with Xerox copies on 24.09.2018 at 10.30 a.m .
Reporting Time : 10.00 a.m to 11.00 a.m
Venue: Room No.205, 2nd Floor, Centre for Cancer Epidemiology, Advanced Centre for Treatment, Research & Education in Cancer, Sector 22, Kharghar, Navi Mumbai – 410210″.
The Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) is the state-of-the-art R&D satellite of the Tata Memorial Centre (TMC), which also includes under its umbrella the Tata Memorial Hospital (TMH), the largest cancer hospital in Asia. ACTREC has the mandate to function as a national centre for treatment, research and education in cancer. TMC is an autonomous grant-in-aid institution of the Department of Atomic Energy (DAE), Government of India. It is registered under the Societies Registration Act (1860) and the Bombay Public Trust Act (1950). Its Governing Council is headed by the Chairman, Atomic Energy Commission, Government of India.
ACTREC comprises of 2 arms – one for basic research and another for clinical research. The basic research building was inaugurated in March 2002 at the new site of ACTREC in Kharghar, Navi Mumbai. In August 2002, the Cancer Research Institute (CRI) shifted in toto from its Parel campus in Mumbai to serve as the basic research arm of ACTREC. The clinical research arm of ACTREC comprising of the Clinical Research Centre (CRC) became functional from March 2005. ACTREC also has a 100-bed hospital fully equipped with state-of-the-art diagnostic and therapeutic facilities. Research investigations at CRI currently focus on molecular mechanisms responsible for causation of major human cancers relevant to India. It is envisaged that in the future, ACTREC will play a greater role in drug development and emerging therapies for treatment and prevention of cancer.
Date of interview: September 24, 2018
Reference Link : Original notification
Website : www.actrec.gov.in